FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

CDER Updates NDA/BLA Filing Review Procedures

[ Price : $8.95]

An updated CDER internal policy outlines procedures for identifying review issues during the filing review of all original NDAs, B...

FDA Urging Electronic Submissions for Citizen Petitions

[ Price : $8.95]

FDA plans to update its administrative regulations in 21 CFR Part 10 to include an electronic method for citizen petition submissi...

Quality System Violations in Jacobus FDA-483

[ Price : $8.95]

FDA releases the inspection observations from a March-April inspection at Jacobus Pharmaceuticals.

FDA Approves Glaxos New COPD Drug

[ Price : $8.95]

FDA approves a GlaxoSmithKline NDA for Anoro Ellipta (umeclidinium and vilanterol inhalation powder) for the once-daily, long-term...

FDA Approves Glaxos Anoro Ellipta to Treat COPD

[ Price : $8.95]

FDA approves GlaxoSmithKlines new combination COPD drug Anoro Ellipta.

Medication Guides Updated for 22 Drugs

[ Price : $8.95]

FDA lists 22 drugs for which Medication Guides have been updated.

FDA, EMA Sharing Generic Drug Bioequivalence Info

[ Price : $8.95]

FDA says it is working with the European Medicines Agency and five European countries on joint inspections of bioequivalence studi...

Health Firms Must Work Closely with FDA: Wharton Profs

[ Price : $8.95]

Wharton School of Business professors say that recent regulatory action against the personal genetic tests marketed by 23andMe spe...

New Regulatory Paradigm Needed for Communications with Doctors: PhRMA

[ Price : $8.95]

PhRMAs general counsel says FDA and industry need to revisit how the biopharmaceutical industry communicates with healthcare profe...

FDA, CMS Extend Parallel Review Pilot

[ Price : $8.95]

Federal Register Notice: FDA and the Centers for Medicare and Medicaid Services will extend a pilot program for an additional two ...